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Background
The human immunodeficiency virus (HIV) type 1 epi-
demic in African countries is mainly due to HIV-1 Sub-
type C compared to United States of America (USA) and
Europe where mainly is B. However many scientists
remain in the dark regarding disease progression of these
Subtypes and their influence on the clinical manifestation
of HIV infection. Prospectively we looked at the associa-
tion between HIV-1 subtypes A, B, C, D and non-reactive
viruses as well as the rate of disease progression in a
longitudinal study of seropositive adults from Northern
Tanzania.
Methods
A total of 104 adults were selected from PRIOR-6 study
aiming on ARV adherence among HIV/AIDS patients on
ART in Moshi Kilimanjaro for HIV-1 subtypes and char-
acterization. The CD4+ cell counts were was measured at
baseline and at three, six and twelve months. The chi-
square and odds ratios were used for the analysis to mea-
sure the association between viral subtype and the rate of
disease progression
Results
Relative to patients with subtypes C, patients with subtype
D experienced the most rapid progression to World
Health Organization clinical stage 4 with odds ratio of 12
and 95% confidence interval (CI), 1.67–68.56) and to a
CD4+ cell count of <200 cells/mm3 during our one year
follow up.
Conclusion
We noticed heterogeneity in the rates of disease progres-
sion of HIV-1 disease in infected people, basing on the
infecting subtype. Even at the baseline CD4+ count
patients with Subtype D had the very low count followed
by C and A was the least. Subtype D was associated with
the most rapid progression of the disease, compared to the
subtype A, or C of viruses in our study.
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